70012980 (ranitidine hydrochloride)
(Ranitidine Hydrochloride)Watson Laboratories, Inc.
Usage: Ranitidine tablets are indicated for short-term treatment and maintenance of active duodenal and gastric ulcers, treatment of pathological hypersecretory conditions, GERD, and erosive esophagitis. Symptomatic relief often occurs within 24 hours. Safety for extended use beyond specified periods has not been established.